Activest Wealth Management’s Edwards Lifesciences EW Stock Holding History

Activest Wealth Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.35K	Sell	26 -87	-77%	-$7.29K	﹤0.01%	831
2026 Q1	$9.02K	Sell	113 -171	-60%	-$14.1K	﹤0.01%	707
2025 Q4	$24.2K	Buy	284 +114	+67%	+$9.36K	﹤0.01%	462
2025 Q3	$13.2K	Buy	170 +26	+18%	+$2.03K	﹤0.01%	444
2025 Q2	$11.2K	Sell	144 -21	-13%	-$1.57K	﹤0.01%	409
2025 Q1	$12K	Buy	165 +161	+4,025%	+$11.5K	﹤0.01%	369
2024 Q4	$296	Sell	4 -8	-67%	-$560	﹤0.01%	594
2024 Q3	$804	Sell	12 -2,188	-99%	-$159K	﹤0.01%	471
2024 Q2	$203K	Buy	+2,200	New	+$195K	0.07%	81

Other funds holding EW

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

BHIA

Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return

NONA

Ninety One North America New York $2.13B AUM 9.16% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

SIM

Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return

TIM

Triodos Investment Management Driebergen-Rijsenburg, Netherlands $1.64B AUM 37.98% 1-Year Est. Return

Activest Wealth Management's EW Position: Q2 2026 in Review

Activest Wealth Management reduced its Edwards Lifesciences (EW) stake by 77% in Q2 2026, selling an estimated $7.29K and leaving 26 shares worth $2.35K. The position accounts for ﹤0.01% of the portfolio, ranked #831.

Activest Wealth Management first reported a position in EW in Q2 2024 and has held it in 9 quarters since. The position peaked at $203K in Q2 2024. 493 funds tracked by Wall St. Rank hold EW as of Q2 2026.

Activest Wealth Management held 26 shares of Edwards Lifesciences worth $2.35K as of Q2 2026.
Activest Wealth Management sold 87 Edwards Lifesciences shares in Q2 2026, an estimated $7.29K.
Edwards Lifesciences made up ﹤0.01% of Activest Wealth Management's portfolio in Q2 2026, its #831 holding.
Activest Wealth Management first reported a position in Edwards Lifesciences in Q2 2024 and has held it in 9 quarters since.
Activest Wealth Management's Edwards Lifesciences position peaked at $203K in Q2 2024.
493 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Activest Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.